Martha Louzada - Concepedia

Author

Martha Louzada

Also Known As

Alejandro Lazo-Langner, M. LOUZADA, M. Louzada, M.L. Louzada, Martha L. Louzada, Martha L Louzada, Martha L. Louzada, Martha Louzada

123

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Western University Ottawa Hospital Dalhousie University Princess Margaret Cancer Centre London Health Sciences Centre

About

Martha Louzada is an author at Western University specializing in medicine, oncology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	328
2	Health Sciences	4	4	117
3	Public Health	3	3	87
4	Blood Transplantation	1	1	12
5	Emergency Medicine	1	1	35

Martha Louzada

Publications

727

Citations

H-Index

Page 1

	Year	Citations
Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism Martha Louzada, Marc Carrier, Alejandro Lazo‐Langner, Circulation	2012	221
A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2) Gwynivere A Davies, Alejandro Lazo‐Langner, Esteban Gándara, Thrombosis Research Central Venous CatheterPulmonary EmbolismThrombosisVenous DiseaseCatheter 2	2017	95
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis, The Lancet Haematology Hematological MalignancyOncologyTransplantationHematologyClinical Trials	2022	44
Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study Nick van Es, Martha Louzada, Marc Carrier, Thrombosis Research ThrombosisPulmonary EmbolismEpidemiologyOncologyCancer Epidemiology	2018	40
Acute Aortic Thrombosis in Patients Receiving Cisplatin-Based Chemotherapy Dellano D. Fernandes, Martha Louzada, Carolina A. Souza, Current Oncology Surgical OncologyAcute Aortic ThrombosisActive CancerPathologyPharmacotherapy	2011	36
Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin Sarag Burgess, Natalie Crown, Martha Louzada, Journal of Thrombosis and Haemostasis ThrombosisVenous ThrombosisCardiovascular DiseaseMedicineRisk Scores	2013	35
Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study) Leonard Minuk, Shannon Jackson, Alfonso Iorio, Haemophilia	2015	32
Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial Suzanne Trudel, Arleigh McCurdy, Martha Louzada, Nature Medicine	2024	30
Part 1 Results of a Dose-Finding Study of Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM) Suzanne Trudel, Arleigh McCurdy, Heather J. Sutherland, Blood	2021	22
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis Arleigh McCurdy, Hira Mian, Richard LeBlanc, Blood Cancer Journal Hematological MalignancyOncologyMarrow TransplantationTransplantationStem Cell Transplantation	2023	21

Page 1